相关实验视频

Updated: Jan 8, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

瘤衍生的外体和免疫细胞在骨髓瘤进展和向治疗中的作用

Jingchao Wang¹, Kuohao Shi¹

¹Translational Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.

Frontiers in immunology

|December 12, 2025

概括

骨髓瘤治疗面临着其侵略性和对疗法的耐药性等挑战. 向瘤免疫微环境 (TIME) 和瘤衍生的外体,为有效的骨髓瘤疗法提供了新的希望.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物化学生物化学

背景情况:

骨髓瘤是一种主要的骨癌,其生存率很低,特别是在复发或转移的病例中.
由于瘤的攻击性和治疗耐药性,传统治疗的有效性有限.
瘤免疫微环境 (TIME) 和外体生物学是骨髓瘤进展和免疫逃避的关键因素.

研究的目的:

审查免疫细胞和瘤衍生的外体在骨髓瘤中的作用.
评估 osteosarcoma 的新兴免疫治疗策略.
探索基于外体组的诊断和治疗的翻译潜力.

主要方法:

骨髓瘤免疫学和外体生物学的文献综述.
对当前免疫治疗策略和临床试验的分析.
讨论针对 TIME 和外体细胞的综合治疗方法.

主要成果:

与瘤相关的巨细胞 (TAMs) 在骨髓瘤中促进免疫抑制.
外体细胞通过携带致癌和免疫抑制因素来促进瘤的进展.
外体细胞调节关键信号通路,如Wnt/β-catenin和TGF-β.

结论:

向TAM和外体介导途径对于克服骨髓瘤耐药性至关重要.
新兴的免疫疗法,如检查点抑制剂和CAR-T细胞,显示出有希望的结果.
结合TIME和外体向的综合治疗策略可能会改善骨髓瘤患者的治疗结果.

关键词:

在外基因组中,外基因组是外基因组.免疫检查点抑制剂免疫检查点抑制剂免疫抑制是一种免疫抑制.免疫疗法免疫疗法骨质肉瘤是骨质肉瘤的一种疾病.与瘤相关的巨细胞.

更多相关视频

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...